Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 21, 2020 - Issue 8
Submit an article Journal homepage
764
Views
10
CrossRef citations to date
0
Altmetric
Drug Evaluation

Clinical pharmacology of imeglimin for the treatment of type 2 diabetes

Karl Sebastian Johanssona Department of Clinical Pharmacology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, DenmarkView further author information
,
Andreas Brøndena Department of Clinical Pharmacology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark;b Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, DenmarkView further author information
,
Filip Krag Knopb Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark;c Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;d Steno Diabetes Center, Gentofte, Denmark;e Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkView further author information
&
Mikkel Bring Christensena Department of Clinical Pharmacology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark;b Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, DenmarkCorrespondence[email protected]
View further author information
Pages 871-882 | Received 08 Oct 2019, Accepted 10 Feb 2020, Published online: 28 Feb 2020

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Karl Sebastian Johansson, David Peick Sonne, Filip Krag Knop & Mikkel Bring Christensen. (2020) What is on the horizon for type 2 diabetes pharmacotherapy? – An overview of the antidiabetic drug development pipeline. Expert Opinion on Drug Discovery 15:11, pages 1253-1265.
Read now
Yoshifumi Saisho. (2020) An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspective. Expert Opinion on Pharmacotherapy 21:13, pages 1565-1577.
Read now

Articles from other publishers (8)

Xisto Antonio de Oliveira Neto, Leticia Barssotti, Ana Thereza Fiori-Duarte, Helena Cristina de Lima Barbosa & Daniel Fábio Kawano. (2023) Entering the Sugar Rush Era: Revisiting the Antihyperglycemic Activities of Biguanides after a Century of Metformin Discovery. Current Medicinal Chemistry 30:22, pages 2542-2561.
Crossref
Masaki Okada, Hiroshi Bando, Noboru Iwatsuki, Kazuki Sakamoto & Tomoya Ogawa. (2023) Relieved Depressive State and Glycemic Control in Type 2 Diabetes (T2D) Patient Treated by Imeglimin (Twymeeg). Asploro Journal of Biomedical and Clinical Case Reports 6:2, pages 116-123.
Crossref
Ali A. Alamer, Nasser B. Alsaleh, Alhassan H. Aodah, Abdullah A. Alshehri, Fahad A. Almughem, Sarah H. Alqahtani, Haya A. Alfassam & Essam A. Tawfik. (2023) Development of Imeglimin Electrospun Nanofibers as a Potential Buccal Antidiabetic Therapeutic Approach. Pharmaceutics 15:4, pages 1208.
Crossref
Atsushi Kitamura, Takuya Yumizaki, Tomoe Kondo, Hisakuni Sekino & Hiroyoshi Kakuyama. (2023) Pharmacokinetics and Safety of Imeglimin in Japanese Patients With Impaired Renal Function. The Journal of Clinical Pharmacology.
Crossref
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh & Anoop Misra. (2023) Efficacy and safety of imeglimin in type 2 diabetes: A systematic review and meta-analysis of randomized placebo-controlled trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 17:2, pages 102710.
Crossref
Yoshiko Tomita, Emma Hansson, Florent Mazuir, Gustaf J Wellhagen, Qing Xi Ooi, Enrica Mezzalana, Atsushi Kitamura, Daisuke Nemoto & Sébastien Bolze. (2022) Imeglimin population pharmacokinetics and dose adjustment predictions for renal impairment in Japanese and Western patients with type 2 diabetes. Clinical and Translational Science 15:4, pages 1014-1026.
Crossref
Nina Krako Jakovljevic, Kasja Pavlovic, Aleksandra Jotic, Katarina Lalic, Milica Stoiljkovic, Ljiljana Lukic, Tanja Milicic, Marija Macesic, Jelena Stanarcic Gajovic & Nebojsa M. Lalic. (2021) Targeting Mitochondria in Diabetes. International Journal of Molecular Sciences 22:12, pages 6642.
Crossref
Chevalier Clémence, Pascale Fouqueray & Bolze Sébastien. (2020) In Vitro Investigation, Pharmacokinetics, and Disposition of Imeglimin, a Novel Oral Antidiabetic Drug, in Preclinical Species and Humans. Drug Metabolism and Disposition 48:12, pages 1330-1346.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.